BVAXF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

BioVaxys Technology (BVAXF) Ownership - Who owns BioVaxys Technology?

BioVaxys Technology Corp is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix â€˜neoantigenâ€™ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

146 Thirtieth Street

Phone

+1 646 452-7054

Employees

Web

https://www.biovaxys.com

Details

Group

Domestic Stock Funds

Fundamentals

BVAXF

Capitalization

10.4M

P/E Ratio

N/A

Risk (Beta)

3.01

Dividend Yield

N/A

Total Cash

157K

Total Cash/Share

0.00

Total Debt

67.7K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

-1.74M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-0.02

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

28.3M

Current Ratio

0.42

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-4.13M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-402.05

Shares Held By Institutions

Shares Outstanding - Current

292M

Total Liabilities

3.02M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-8.274

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology